| 1 | Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach. (Mau LW, Preussler JM, Burns LJ, Leppke S, Majhail NS, Meyer CL, Mupfudze T, Saber W, Steinert P, Vanness DJ) Pharmacoeconomics 2020 May;38(5):515-526 3 Citations |
| 1 | Upper extremity disability and quality of life after breast cancer treatment in the Greater Plains Collaborative clinical research network. (Chrischilles EA, Riley D, Letuchy E, Koehler L, Neuner J, Jernigan C, Gryzlak B, Segal N, McDowell B, Smith B, Sugg SL, Armer JM, Lizarraga IM) Breast Cancer Res Treat 2019 Jun;175(3):675-689 32 Citations |
| 1 | Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation. (Preussler JM, Meyer CL, Mau LW, Majhail NS, Denzen EM, Edsall KC, Farnia SH, Saber W, Burns LJ, Vanness DJ) Biol Blood Marrow Transplant 2017 Jun;23(6):1021-1028 31 Citations |
| 1 | Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. (Vaughn JE, Sorror ML, Storer BE, Chauncey TR, Pulsipher MA, Maziarz RT, Maris MB, Hari P, Laport GG, Franke GN, Agura ED, Langston AA, Rezvani AR, Storb R, Sandmaier BM, Maloney DG) Cancer 2015 Oct 15;121(20):3709-16 32 Citations |
| 1 | Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. (Lencioni R, Aliberti C, de Baere T, Garcia-Monaco R, Narayanan G, O'Grady E, Rilling WS, Walker D, Martin RC) J Vasc Interv Radiol 2014 Mar;25(3):365-9 50 Citations |
| 1 | Empirical amphotericin B therapy on day 4 or day 8 of febrile neutropenia. (Malhotra P, Makkar A, Guru Murthy GS, Varma N, Varma S, Chakrabarti A) Mycoses 2014 Feb;57(2):110-5 8 Citations |
| 1 | Approach to the patient with an infantile hemangioma. (Holland KE, Drolet BA) Dermatol Clin 2013 Apr;31(2):289-301 25 Citations |
| 1 | Optimizing drug therapy in the surgical intensive care unit. (Peppard WJ, Peppard SR, Somberg L) Surg Clin North Am 2012 Dec;92(6):1573-620 2 Citations |
| 1 | New strategies for advanced neuroendocrine tumors in the era of targeted therapy. (Dong M, Phan AT, Yao JC) Clin Cancer Res 2012 Apr 01;18(7):1830-6 44 Citations |
| 2 | Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. (Reece DE, Vesole DH, Shrestha S, Zhang MJ, Pérez WS, Dispenzieri A, Milone GA, Abidi M, Atkins H, Bashey A, Bredeson CN, Boza WB, Freytes CO, Gale RP, Gajewski JL, Gibson J, Hale GA, Kumar S, Kyle RA, Lazarus HM, McCarthy PL, Pavlovsky S, Roy V, Weisdorf DJ, Wiernik PH, Hari PN) Clin Lymphoma Myeloma Leuk 2010 Dec;10(6):458-63 22 Citations |
| 3 | Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. (Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P) Biol Blood Marrow Transplant 2010 Mar;16(3):395-402 51 Citations |
| 1 | Factorial designs in clinical trials: options for combination treatment studies. (Couper DJ, Hosking JD, Cisler RA, Gastfriend DR, Kivlahan DR) J Stud Alcohol Suppl 2005 Jul(15):24-32; discussion 6-7 17 Citations |
| 1 | Assessing nondrinking outcomes in combined pharmacotherapy and psychotherapy clinical trials for the treatment of alcohol dependence. (Cisler RA, Kivlahan DR, Donovan D, Mattson ME) J Stud Alcohol Suppl 2005 Jul(15):110-8; discussion 92-3 13 Citations |
| 1 | Quality of life as an outcome measure in alcoholism treatment research. (Donovan D, Mattson ME, Cisler RA, Longabaugh R, Zweben A) J Stud Alcohol Suppl 2005 Jul(15):119-39; discussion 92-3 173 Citations |
| 1 | Design and analysis of trials of combination therapies. (Hosking JD, Cisler RA, Couper DJ, Gastfriend DR, Kivlahan DR, Anton RF) J Stud Alcohol Suppl 2005 Jul(15):34-42; discussion 33 9 Citations |
| 1 | Cost methodology of COMBINE. (Zarkin GA, Bray JW, Mitra D, Cisler RA, Kivlahan DR) J Stud Alcohol Suppl 2005 Jul(15):50-5; discussion 33 19 Citations |
| 1 | What's new in ... clinical pharmacology and therapeutics. (Kochar MS, Campbell WB) Wis Med J 1996 Sep;95(9):645-6 |
| 1 | The accuracy of medication data in an outpatient electronic medical record. (Wagner MM, Hogan WR) J Am Med Inform Assoc 1996;3(3):234-44 100 Citations |
| 1 | Free-text fields change the meaning of coded data. (Hogan WR, Wagner MM) Proc AMIA Annu Fall Symp 1996:517-21 23 Citations |
| 1 | Using databases in pharmacies. (MacKinnon G, Wuller W) Healthc Inform 1993 Jun;10(6):34-6, 38, 40 |
| 1 | Computer-based patient simulations: hospital pharmacists' performance and opinions. (MacKinnon GE 3rd, Pitterle ME, Boh LE, DeMuth JE) Am J Hosp Pharm 1992 Nov;49(11):2740-5 6 Citations |
| 1 | Drug usage in the elderly. (Lund MD, Duthie EH Jr) Wis Med J 1982 Aug;81(8):21-5 2 Citations |
